Leonard Kruimer
Chairman bei BIOINVENT INTERNATIONAL AB
Vermögen: 2 Mio $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Leonard Kruimer
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.
33
| Extinct | Pharmaceuticals: Major | 33 |
| Public Company | Pharmaceuticals: Major | 31 | |
| Public Company | Biotechnology | 30 | |
| Public Company | Pharmaceuticals: Major | 18 | |
| Public Company | Pharmaceuticals: Major | 16 | |
Pricewaterhouse & Co.
12
| Extinct | Miscellaneous Commercial Services | 12 |
| Public Company | Biotechnology | 5 | |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands.
3
| Extinct | Pharmaceuticals: Major | 3 |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands.
3
| Subsidiary | Biotechnology | 3 |
T.I.P. Europe Ltd.
 T.I.P. Europe Ltd. Other TransportationTransportation T.I.P. Europe Ltd. engaged in the operation of warehousing and storage facilities for land transport activities. The company was founded on March 26, 1986 and was headquartered in London, the United Kingdom.
1
| Extinct | Other Transportation | 1 |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands.
1
| Holding Company | Medical/Nursing Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Leonard Kruimer
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Executive Officer | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Public Communications Contact Director/Board Member | |
| Nyenrode Business Universiteit | College/University | Graduate Degree Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SYNGENTA | Chemicals: Agricultural | Director of Finance/CFO Corporate Secretary | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer | |
| University of Cambridge | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
| McGill University | College/University | Graduate Degree Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Investor Relations Contact Director/Board Member | |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| University of Amsterdam | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
Janssen Vaccines & Prevention BV
 Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer General Counsel Chief Operating Officer | |
| University of Lund | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree | |
| Erasmus University Rotterdam | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Utrecht | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Groningen | College/University | Doctorate Degree Graduate Degree | |
| University of Basel | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SPEXIS AG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor | |
SuppreMol GmbH
 SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer Corporate Officer/Principal | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Chairman Sales & Marketing | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| MENDUS AB | Biotechnology | Director/Board Member Chairman | |
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Biotechnology | Director/Board Member Director/Board Member | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Founder General Counsel | |
Impatients NV
 Impatients NV Miscellaneous Commercial ServicesCommercial Services Impatients N.V. operates an online platform for drug innovations. It provides physicians and patients that are excluded from clinical trials access to drugs in development via early access programs. The company was founded by Ronald Brus, SJaak Vink, Govert J. Schouten, Witt Jan, Erdem Yavuz, and René Beukema in 2012 and is headquartered in Amsterdam, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
| INVENTIVA | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Basilea Pharmaceutica China Ltd.
 Basilea Pharmaceutica China Ltd. Pharmaceuticals: MajorHealth Technology Part of Basilea Pharmaceutica AG, Basilea Pharmaceutica China Ltd. engages in research, development, and commercialization of anti-infective and anti-cancer drugs. The private company is based in Nantong, China. The Chinese company was founded in 2002. The CEO is You Zhou. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Leyden Laboratories B.V.
 Leyden Laboratories B.V. Miscellaneous Commercial ServicesCommercial Services Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder |
Statistik
International
| Niederlande | 11 |
| Schweiz | 9 |
| Schweden | 8 |
| Vereinigte Staaten | 7 |
| Dänemark | 5 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Process Industries | 2 |
| Health Services | 2 |
Operativ
| Director/Board Member | 497 |
| Corporate Officer/Principal | 184 |
| Independent Dir/Board Member | 142 |
| Chairman | 114 |
| Chief Executive Officer | 84 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Jane M. Birgitta Stymne Göransson | 50 |
| Alain Munoz | 38 |
| Alf Gunnar Martin Nicklasson | 31 |
| Catherine Moukheibir | 29 |
| Nanna Liebach Lüneborg | 29 |
| Alain Parthoens | 29 |
| Jeffrey Berkowitz | 26 |
| Thomas Werner | 25 |
| Thomas O. Hecht | 24 |
| Rosemary Crane | 23 |
| Bernd Seizinger | 23 |
| Vincent Ossipow | 22 |
| Michael Owen | 20 |
| Deborah Jorn | 20 |
- Börse
- Insiders
- Leonard Kruimer
- Unternehmensverbindungen
